NetworkNewsBreaks – Lexaria Bioscience Corp. (NA
Post# of 420
(Total Views: 111)
Posted On: 12/08/2023 2:59:53 PM
NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Update on FDA Application for Investigational Drug
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has filed a spoofing complaint in the U.S. District Court for the Southern District of New York. The complaint, filed on Dec. 6, 2023, alleges that UBS Securities LLC, IMC Financial Markets and Clear Street Markets LLC engaged in a scheme using spoofing to manipulate the market price of Mullen shares. The company noted that the claim for the spoofing litigation is attached to the company’s Form 8-K, which it filed this week with the Securities and Exchange Commission (“SEC”). According to the announcement, Mullen believes that the spoofing litigation provides greater potential to recover damages based on the nature of the claims and the duration of the two-year period when the spoofing allegedly occurred. In addition, Mullen has dismissed the lawsuit it had filed in August in the U.S. District Court for the Southern District of New York; the litigation alleged that certain broker-dealers were attempting to manipulate the share price of the company’s securities focusing on short-selling claims. “My focus continues to provide transparency and to protect the long-term value for our company and our stockholders,” said Mullen CEO and chair David Michery in the press release. “We believe that the spoofing litigation provides the best opportunity to sustain our claims as well as recover damages based on the defendant’s market manipulation.”
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has filed a spoofing complaint in the U.S. District Court for the Southern District of New York. The complaint, filed on Dec. 6, 2023, alleges that UBS Securities LLC, IMC Financial Markets and Clear Street Markets LLC engaged in a scheme using spoofing to manipulate the market price of Mullen shares. The company noted that the claim for the spoofing litigation is attached to the company’s Form 8-K, which it filed this week with the Securities and Exchange Commission (“SEC”). According to the announcement, Mullen believes that the spoofing litigation provides greater potential to recover damages based on the nature of the claims and the duration of the two-year period when the spoofing allegedly occurred. In addition, Mullen has dismissed the lawsuit it had filed in August in the U.S. District Court for the Southern District of New York; the litigation alleged that certain broker-dealers were attempting to manipulate the share price of the company’s securities focusing on short-selling claims. “My focus continues to provide transparency and to protect the long-term value for our company and our stockholders,” said Mullen CEO and chair David Michery in the press release. “We believe that the spoofing litigation provides the best opportunity to sustain our claims as well as recover damages based on the defendant’s market manipulation.”
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Lexaria Bioscience Corp. (LEXX) Stock Research Links
Scroll down for more posts ▼